We found that using siRNA to inhibit CCN2 mRNA expression in human SSc lung fibroblasts reduced constitutive expression of fibronectin, and TGF-β-induced expression of other fibrotic markers. This evidence concerns the gene CCN2 and systemic sclerosis.